|
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
RECRUITINGN/ASponsored by The Cleveland Clinic
Actively Recruiting
PhaseN/A
SponsorThe Cleveland Clinic
Started2023-09-19
Est. completion2026-06
Eligibility
Age40 Years+
SexMALE
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT05868668
Summary
The purpose of this study to perform a randomized, sham controlled analysis of the effectiveness of both fSWT and rWT in the relief of erectile dysfunction and chronic pelvic pain syndrome.
Eligibility
Age: 40 Years+Sex: MALEHealthy volunteers accepted
Erectile Dysfunction Group (ED) Inclusion Criteria (ED): (all of the following) 1. Cis-gendered heterosexual adult males18 years old 2. Stable relationship of more than 3 months duration with currently willing sexual partner and desire for penetration. 3. Mild to moderate organic erectile dysfunction (IIEF-EF score 11-25) in the last 3 months 4. If ED responsive or partially responsive to current use of PDE5I, participant must be willing to discontinue PDE5I for 4 weeks prior to trial and remain off PDE5I for the duration of the study. Partially responsive ED is defined as inadequate response for desired sexual activity, or poorly maintained erection despite initially good response. 5. Agreeable to attempt sexual intercourse at least 4 times per month for duration of study without being under the influence of alcohol or recreational drugs 6. Morning total testosterone level over 300ng/dL Exclusion Criteria (ED): 1. Nerve-injury related ED (/spinal cord injury, severe lumbosacral disorder (radiculopathy, spinal stenosis) or other neurological disease affecting erectile functions (e.g, multiple sclerosis, alzheimer's disease, parkinsons disease, amyotrophic lateral sclerosis) 2. Untreated hypogonadism (morning total testosterone \<300 ng/dL) or on androgen deprivation therapy in the last 12 months 3. Predominately psychogenic ED based upon expert clinician opinion 4. Peyronie's disease, palpable plaque or curvature/penile anatomic abnormality that affects penetrative intercourse to any degree 5. History of non-superficial penile surgery (e.g, penile prosthesis, penectomy, plication, grafting) 6. History of penile injury or trauma (e.g, priapism, penile fracture) 7. Use of intracavernosal injection for ED within the last year 8. If diabetic, HbA1c 8% or higher within the past 12 months 9. Known corporal veno-occlusive dysfunction based on prior Doppler penile ultrasound 10. Current tobacco smoker, or has smoked in the past year 11. Poorly controlled hyperlipidemia 12. Poorly controlled hypertension 13. Severe cardiac disease or history of myocardial infarction 14. History of psychiatric disorder including bipolar disorder, current moderate or severe depression 15. Patients currently using SSRI or psychotropic medication 16. Severe ED based on IIEF-EF (score 10 or below) 17. Current acute prostatitis Chronic Pelvic Pain Syndrome Group: Inclusion Criteria (CPPS): (all of the following) 1. Adult males ≥18 years old 2. Chronic pelvic pain not explained by concurrent urinary tract infections. urine) 3. Willing to do PFPT Exclusion criteria (CPPS): 1. Nerve-injury related pelvic pain (history of /spinal cord injury, severe lumbosacral disorder (radiculopathy, spinal stenosis) or other neurological disease affecting pain in the pelvic region(Multiple sclerosis, Alzheimer's, Parkinsons disease) 2. Acute prostatitis or any acute infection of the pelvic region 3. History of pelvic trauma
Conditions8
CancerChronic Pelvic Pain SyndromeChronic ProstatitisErectile DysfunctionErectile Dysfunction Due to Arterial DiseaseErectile Dysfunction Due to Arterial InsufficiencyErectile Dysfunction Following Radiation TherapyErectile Dysfunction Following Radical Prostatectomy
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorThe Cleveland Clinic
Started2023-09-19
Est. completion2026-06
Eligibility
Age40 Years+
SexMALE
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT05868668